Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase Myositis-related interstitial lung disease and antisynthetase syndrome by Joshua Solomon, Jeffrey J Swigris, Kevin K Brown

Get full text

Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how? by Jeffrey J Swigris, Kerri Aronson, Susan S Jacobs, Dawn Repola

Get full text

A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis by Jeffrey J. Swigris, Kerri Aronson, Evans R. Fernández Pérez

Get full text

Performance of pulmonary artery dimensions measured on high-resolution computed tomography scan for identifying pulmonary hypertension by Pailin Ratanawatkul, Andrea Oh, J. Caleb Richards, Jeffrey J. Swigris

Get full text

Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease by Jeffrey J Swigris, Sonye Danoff, Paul F Dellaripa, Joshua J Solomon, Tracy J Doyle

Get full text

Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease by Rui-Li Pan, Jeffrey J. Swigris, Yan-Wei Zhao, Ai-Min Guo, Qing Wu, Si-Jia Li

Get full text

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases by Jeffrey J. Swigris, Kevin K. Brown, Rayid Abdulqawi, Ketan Buch, Daniel F. Dilling, Dirk Koschel, Krishna Thavarajah, Rade Tomic, Yoshikazu Inoue

Get full text

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis by Bridget A. Graney, Frederick S. Wamboldt, Susan Baird, Tara Churney, Kaitlin Fier, Marjorie Korn, Mark McCormick, Thomas Vierzba, Jeffrey J. Swigris

Get full text

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort by Vissagan Gopalakrishnan, Amanda M. Jones, Patricia Julien-Williams, Tania Machado, Robert L. Danner, Jeffrey J. Swigris, Robert Paine, Jay N. Lozier, Joel Moss

Get full text

Development and initial validation of a disease-specific instrument to measure health-related quality of life in hypersensitivity pneumonitis by Kerri I. Aronson, Mangala Rajan, Janani Varadarajan, Tessy K. Paul, Jeffrey J. Swigris, Jamuna K. Krishnan, Robert J. Kaner, Fernando J. Martinez, Monika M. Safford, Laura C. Pinheiro

Get full text

Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis by Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

Get full text

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib by Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris, Joao A de Andrade

Get full text

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

Get full text